Al-Modawat Specialized Medical Company (TADAWUL:9594)
Saudi Arabia · Delayed Price · Currency is SAR 5.70
0.00 (0.00%)
Jun 11, 2026, 3:10 PM AST
TADAWUL:9594 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 128.05 | 121.82 | 75.49 | 74.31 | 58.57 | 40.84 | |
Revenue Growth (YoY) | 49.58% | 61.38% | 1.59% | 26.88% | 43.41% | - |
Cost of Revenue | 75.12 | 69.76 | 45.09 | 33.93 | 30.71 | 26.17 |
Gross Profit | 52.93 | 52.06 | 30.4 | 40.37 | 27.85 | 14.67 |
Selling, General & Admin | 27.05 | 24.23 | 19.35 | 15.67 | 14.13 | 15.56 |
Other Operating Expenses | 0.4 | 0.4 | - | - | - | -0.42 |
Operating Expenses | 30.89 | 28.08 | 22.36 | 18.5 | 15.71 | 15.14 |
Operating Income | 22.04 | 23.99 | 8.04 | 21.88 | 12.14 | -0.48 |
Interest Expense | -2.72 | -2.01 | -1.13 | -1.13 | -0.69 | -0.22 |
Other Non Operating Income (Expenses) | -1.01 | -1.03 | -0.01 | 0.04 | -0.52 | - |
EBT Excluding Unusual Items | 18.31 | 20.95 | 6.9 | 20.78 | 10.92 | -0.69 |
Other Unusual Items | -0.66 | -0.66 | -0.11 | -1.33 | -0.31 | - |
Pretax Income | 17.64 | 20.28 | 6.79 | 19.45 | 10.61 | -0.69 |
Income Tax Expense | 1.32 | 1.31 | 0.72 | 0.85 | 0.33 | 0.03 |
Earnings From Continuing Operations | 16.32 | 18.98 | 6.07 | 18.59 | 10.28 | -0.73 |
Net Income | 16.32 | 18.98 | 6.07 | 18.59 | 10.31 | -2.21 |
Net Income to Common | 16.32 | 18.98 | 6.07 | 18.59 | 10.31 | -2.21 |
Net Income Growth | 54.87% | 212.44% | -67.33% | 80.28% | - | - |
Shares Outstanding (Basic) | 72 | 71 | 69 | 57 | 57 | - |
Shares Outstanding (Diluted) | 72 | 71 | 69 | 57 | 57 | - |
Shares Change (YoY) | 1.43% | 2.82% | 21.57% | - | - | - |
EPS (Basic) | 0.23 | 0.27 | 0.09 | 0.33 | 0.18 | - |
EPS (Diluted) | 0.23 | 0.27 | 0.09 | 0.33 | 0.18 | - |
EPS Growth | 52.69% | 203.88% | -73.13% | 80.28% | - | - |
Free Cash Flow | -0.34 | 1.9 | -8.52 | 9.68 | 2.32 | -2.26 |
Free Cash Flow Per Share | -0.01 | 0.03 | -0.12 | 0.17 | 0.04 | - |
Dividend Per Share | - | - | - | 0.233 | - | - |
Gross Margin | 41.34% | 42.74% | 40.27% | 54.33% | 47.56% | 35.92% |
Operating Margin | 17.21% | 19.69% | 10.65% | 29.44% | 20.73% | -1.17% |
Profit Margin | 12.75% | 15.58% | 8.04% | 25.02% | 17.61% | -5.40% |
Free Cash Flow Margin | -0.27% | 1.56% | -11.29% | 13.03% | 3.96% | -5.53% |
EBITDA | 25.79 | 27.74 | 10.38 | 23.62 | 13.69 | 0.93 |
EBITDA Margin | 20.14% | 22.77% | 13.75% | 31.79% | 23.37% | 2.29% |
D&A For EBITDA | 3.75 | 3.75 | 2.34 | 1.74 | 1.55 | 1.41 |
EBIT | 22.04 | 23.99 | 8.04 | 21.88 | 12.14 | -0.48 |
EBIT Margin | 17.21% | 19.69% | 10.65% | 29.44% | 20.73% | -1.17% |
Effective Tax Rate | 7.50% | 6.44% | 10.56% | 4.39% | 3.09% | - |
Advertising Expenses | - | 1.55 | 0.97 | 0.16 | 0.08 | - |